References
- BrokstadKAErikssonJCCoxRJParenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosaJ Infect Dis2002185787888411920311
- WuHYNguyenHHRussellMWNasal lymphoid tissue (NALT) as a mucosal immune inductive siteScand J Immunol19974655065139393634
- TacchiLMusharrafiehRLarragoiteETNasal immunity is an ancient arm of the mucosal immune system of vertebratesNat Commun20145520525335508
- PoliquinJFCrepeauJImmune defence mechanisms of the nasal mucosaJ Otolaryngol198514280843877817
- NeutraMRKozlowskiPAMucosal vaccines: the promise and the challengeNat Rev Immunol20066214815816491139
- ZhaoLSethAWibowoNNanoparticle vaccinesVaccine201432332733724295808
- ZhuMWangRNieGApplications of nanomaterials as vaccine adjuvantsHum Vaccin Immunother20141092761277425483497
- RyanEJDalyLMMillsKHImmunomodulators and delivery systems for vaccination by mucosal routesTrends Biotechnol200119829330411451471
- ChenLZhuJLiYEnhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexesPLoS One201388e7195323977186
- SloatBRCuiZNasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilliVaccine20062440–416405641316828937
- ZengLMucosal adjuvants: opportunities and challengesHum Vaccin Immunother20161292456245827159278
- FerwerdaGMeyer-WentrupFKullbergBJNeteaMGAdemaGJDectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophagesCell Microbiol200810102058206618549457
- KimHSParkKHLeeHKCurdlan activates dendritic cells through dectin-1 and toll-like receptor 4 signalingInt ImmunoPharmacol201639717827449326
- LiPZhangXChengYPreparation and in vitro immunomodula-tory effect of curdlan sulfateCarbohydr Polym201410285286124507356
- LiPTanHXuDEffect and mechanisms of curdlan sulfate on inhibiting HBV infection and acting as an HB vaccine adjuvantCarbohydr Polym201411044645524906778
- KyriacouHMSteenKERazaAIn vitro inhibition of Plasmodium falciParum rosette formation by curdlan sulfateAntimicrob Agents Chemother20075141321132617283200
- IchiyamaKReddySBZhangLFSulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical applicationPLoS Negl TroP Dis201374e218823658845
- SadeghiAMDorkooshFAAvadiMRPermeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cellsEur J Pharm BioPharm200870127027818492606
- NagpalKSinghSKMishraDNChitosan nanoparticles: a promising system in novel drug deliveryChem Pharm Bull (Tokyo)201058111423143021048331
- van der MerweSMVerhoefJCVerheijdenJHKotzéAFJungingerHETrimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugsEur J Pharm BioPharm200458222523515296951
- van der MerweSMVerhoefJCKotzéAFJungingerHEN-trimethyl chitosan chloride as absorption enhancer in oral peptide drug delivery: development and characterization of minitablet and granule formulationsEur J Pharm BioPharm2004571859114729083
- ThanouMMVerhoefJCRomeijnSGNagelkerkeJFMerkusFWJungingerHEEffects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo tracheaInt J Pharm19991851738210425367
- SahniJKChopraSAhmadFJKharRKPotential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applicationsJ Pharm Pharmacol20086091111111918718113
- KotzeAFLuessenHLde LeeuwBJde BoerBGVerhoefJCJungingerHEN-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2)Pharm Res1997149119712029327448
- XuYDuYHuangRGaoLPreparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrierBiomaterials200324275015502214559015
- XuLJiXZhaoNSongCWangFLiuCThe conjugation of Cu/Zn superoxide dismutase (SOD) to O-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride (O-HTCC) enhances its therapeutic potential against radiation-induced oxidative damagePolym Chem20167918261835
- YuYSunFZhangCWangZLiuJTanHStudy on glyco-modification of endostatin-derived synthetic peptide endostatin 2 (ES2) by soluble chitooligosaccharideCarbohydr Polym201615420421327577911
- SunYWanAPreparation of nanoparticles composed of chitosan and its derivatives as delivery systems for macromoleculesJ Appl Polym Sci20071052552561
- ZhangXGoncalvesRMosserDMThe isolation and characterization of murine macrophagesCurr Protoc Immunol20071052552561
- QuanFSLiZNKimMCImmunogenicity of low-pH treated whole viral influenza vaccineVirology2011417119620221722934
- YusufHKettVCurrent prospects and future challenges for nasal vaccine deliveryHum Vaccin Immunother2017131344527936348
- LaiSKWangYYHanesJMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdv Drug Deliv Rev200961215817119133304
- SayinBSomavarapuSLiXWMono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine deliveryInt J Pharm20083631–213914818662762
- BueterCLLeeCKRathinamVAChitosan but not chitin activates the inflammasome by a mechanism dependent upon phagocytosisJ Biol Chem201128641354473545521862582
- AustynJMGordonSF4/80, a monoclonal antibody directed specifically against the mouse macrophageEur J Immunol198111108058157308288
- van GoolSWVandenberghePde BoerMCeuppensJLCD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation modelImmunol Rev199615347839010719
- ClatzaABonifazLCVignaliDAMorenoJCD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentationJ Immunol2003171126478648714662847
- SansomDMManzottiCNZhengYWhat’s the difference between CD80 and CD86?Trends Immunol200324631431912810107
- KunkelEJButcherECPlasma-cell homingNat Rev Immunol200331082282914523388
- JohanssonELWassénLHolmgrenJJertbornMRudinANasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humansInfect Immun200169127481748611705923